Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Crypto risk tolerance score helps you gauge how much crypto volatility you can handle. This intro explains the score and how to use it to shape your strategy.
26,292 articlesRevolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
Chip stocks led Monday gains while the Dow stumbled, signaling a market with broad dispersion. This article explains ...
Markets rewarded the Trump policy playbook for years, but a shift in Federal Reserve policy could slow the rally. Thi...
A sizable move in the First Trust QTEC fund has traders buzzing. Is the sale a warning sign for overheated AI stocks ...
A routine ethics filing has become a focal point for investors and policymakers. This deep dive explains what the qua...
Greg Abel, stepping into Warren Buffett's shadow, has quietly tripled Berkshire's Alphabet stake. Is this the kind of...
A real-world move shows an investment advisor trims small-cap exposure by millions, signaling risk management and str...
A leading wealth manager just bought a notable position in a small-cap value ETF, highlighting renewed interest in ov...
A large institutional bet on Futu stock sparked headlines as shares fell nearly a quarter. This article breaks down w...
Two popular clean-energy ETFs shape many investors' portfolios. This guide breaks down iShares Global Clean Energy an...
A sudden drop in Navitas stock sent ripples through growth-focused portfolios. This guide explains the key drivers, w...